Rchr
J-GLOBAL ID：201601005518785805
Update date: Jun. 27, 2022
Fukagawa Satoshi
フカガワ サトシ | Fukagawa Satoshi
Affiliation and department：
Papers (7)：
-
URUSHIYAMA Daichi, FUKAGAWA Satoshi, HIRAKAWA Toyofumi, YOSHIKAWA Ken-Ichi, IZUCHI Daisuke, MIYATA Kohei, KURAKAZU Masamitsu, YOTSUMOTO Fusanori, HIROMATSU Kenji, OTA Eiji, et al. MiR-4535 and MiR-1915-5p in Amniotic Fluid as Predictive Biomarkers for Chorioamnionitis. Future Science OA. 2021
-
MIYAMOTO Shingo, IZUCHI Daisuke, FUKAGAWA Satoshi, YOTSUMOTO Fusanori, YOSHIKAWA Ken-Ichi, KIYOSHIMA Chihiro, NAN Son-U, MIYATA Kohei, ITO Tomohiro, KURAKAZU Masamitsu, et al. Association of Serum HB-EGF Value and Response to Chemotherapy in Patients with Recurrent Ovarian Cancer. Anticancer Res. 2018. 38. 7. 4347-4351
-
Kohei Miyata, Fusanori Yotsumoto, Satoshi Fukagawa, Chihiro Kiyoshima, Nam Sung Ouk, Daichi Urushiyama, Tomohiro Ito, Takahiro Katsuda, Masamitsu Kurakazu, Ryota Araki, et al. Serum Heparin-binding Epidermal Growth Factor-like Growth Factor (HB-EGF) as a Biomarker for Primary Ovarian Cancer. ANTICANCER RESEARCH. 2017. 37. 7. 3955-3960
-
Satoshi Fukagawa, Fusanori Yotsumoto, Takashi Odawara, Sadao Manabe, Toyokazu Ishikawa, Shin'Ichiro Yasunaga, Shingo Miyamoto. Antitumour Effects of Intravenous Administration of BK-UM, a Novel Inhibitor of HB-EGF, in Ovarian Cancer Therapy. ANTICANCER RESEARCH. 2017. 37. 7. 3891-3896
-
Fusanori Yotsumoto, Satoshi Fukagawa, Kohei Miyata, Sung Ouk Nam, Takahiro Katsuda, Daisuke Miyahara, Takashi Odawara, Sadao Manabe, Toyokazu Ishikawa, Shin'ichiro Yasunaga, et al. HB-EGF Is a Promising Therapeutic Target for Lung Cancer with Secondary Mutation of EGFR(T790M). ANTICANCER RESEARCH. 2017. 37. 7. 3825-3831
ｍore...
Professional career (1)：
Return to Previous Page
